SEC Company Response from Immunovant, Inc. (IMVT) (CIK 0001764013) (IMVT) — Apr 10, 2020
Immunovant, Inc. (IMVT) (CIK 0001764013)
Date: April 10, 2020 · CIK: 0001764013 · Accession: 0001193125-20-103126
AI Filing Summary & Sentiment
File numbers found in text: 333-237627
Letter
Re: Immunovant, Inc. (the “Company”)
Via EDGAR Submission
April 10, 2020
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Registration Statement on Form S-1 (File No. 333-237627)
Ladies and Gentlemen:
As representatives of the several underwriters of the Company’s proposed public offering of common stock, we hereby join the Company’s request that the effective date of the above-referenced Registration Statement be accelerated so that the above-referenced Registration Statement will be declared effective at 9:00 a.m. (ET) on April 14, 2020, or as soon thereafter as is practicable.
Pursuant to Rule 460 of the General Rules and Regulations of the Securities and Exchange Commission under the Securities Act of 1933, as amended, please be advised that there will be distributed to each underwriter or dealer, who is reasonably anticipated to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
The undersigned advise that they have complied and will continue to comply, and that they have been informed by the participating underwriters and dealers that they have complied with and will continue to comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
[Remainder of Page Intentionally Left Blank]
Very truly yours,
As Representatives of the several Underwriters
Show Raw Text
CORRESP 1 filename1.htm CORRESP Via EDGAR Submission April 10, 2020 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Immunovant, Inc. (the “Company”) Registration Statement on Form S-1 (File No. 333-237627) Ladies and Gentlemen: As representatives of the several underwriters of the Company’s proposed public offering of common stock, we hereby join the Company’s request that the effective date of the above-referenced Registration Statement be accelerated so that the above-referenced Registration Statement will be declared effective at 9:00 a.m. (ET) on April 14, 2020, or as soon thereafter as is practicable. Pursuant to Rule 460 of the General Rules and Regulations of the Securities and Exchange Commission under the Securities Act of 1933, as amended, please be advised that there will be distributed to each underwriter or dealer, who is reasonably anticipated to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus. The undersigned advise that they have complied and will continue to comply, and that they have been informed by the participating underwriters and dealers that they have complied with and will continue to comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. [Remainder of Page Intentionally Left Blank] Very truly yours, As Representatives of the several Underwriters SVB LEERINK LLC By: /s/ Dan Dubin Name: Dan Dubin Title: Vice Chairman UBS SECURITIES LLC By: /s/ Robin Tang Name: Robin Tang Title: Director By: /s/ James Raul Stahlke Name: James Raul Stahlke Title: Associate Director SUNTRUST ROBINSON HUMPHREY, INC. By: /s/ Charles E. Mather Name: Charles E. Mather Title: Managing Director [Signature Page to Acceleration Request]